Skip to content

PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT

CIK 0000315545 · Pharmaceutical Preparations · OTC

  • PROVECTUS PHARMACEUTICALS INC (until 2013-12-18)
  • PROVECTUS PHARMACEUTICAL INC (until 2002-05-15)
  • ZAMAGE DIGITAL IMAGING INC (until 2002-04-01)
  • SPM GROUP INC (until 2001-11-14)
← back to feed
Revenue (TTM)
$700.84K
−45.5% YoY Q1 May 2026
Net Income (TTM)
−$5.56M
−14.8% YoY Q1 May 2026
EPS Diluted (TTM)
$0.00
0.0% YoY Q1 May 2026
Gross Margin
3.5%
Q1 May 2026
Operating Margin
-773.7%
Q1 May 2026
Net Margin
-792.8%
Q1 May 2026
Free Cash Flow (TTM)
−$3.15M
Q1 May 2026
Cash
$223.88K
Q1 May 2026
Total Debt
$500K
Q1 May 2026
Shares Outstanding
420.28M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings